Rational Drug Design Leading to the Identification of a Potent 5-HT(2C) Agonist Lacking 5-HT(2B) Activity

Area of Science:

• Medicinal Chemistry
• Neuropharmacology
• Drug Discovery

Background:

• The serotonin 5-HT2C receptor is a key target for developing treatments for various human disorders.
• Previous efforts yielded potent but moderately selective 5-HT2C receptor agonists.

Purpose of the Study:

• To optimize previously identified 5-HT2B/5-HT2C agonists for improved selectivity and potency.
• To identify a highly selective 5-HT2C receptor agonist.

Main Methods:

• Structural optimization of existing agonist compounds.
• Expansion of the structure-function library.
• Data analysis to guide compound design.

Main Results:

• Identification of (+)-trans-[2-(2-cyclopropylmethoxyphenyl)cyclopropyl]methylamine hydrochloride.
• Achieved high selectivity for the 5-HT2C receptor over the 5-HT2B receptor.
• Demonstrated potent agonism at 5-HT2C receptors with an EC50 of 55 nM.

Conclusions:

• The structural optimization successfully yielded a highly selective 5-HT2C receptor agonist.
• This compound represents a promising lead for developing novel therapeutics targeting 5-HT2C-mediated conditions.